The AMD pipeline presents opportunities via emerging novel therapies focusing on innovative mechanisms such as gene therapy, mitochondria-targeting peptides, and complement inhibition. Key drugs in ...

Despite the recent attention to the potential of developing and using gene therapy to treat several diseases, the therapy was ...

For decades, people with advanced age-related macular degeneration (AMD) — the leading cause of irreversible blindness in ...

“Where this dead retina was a complete blind spot, vision was restored,” Dr. Frank Holz, the study’s lead author and an ...

With AMD prevalence rising, key market opportunities include developing age-targeted therapies and strategic marketing in markets with the highest growth projections, like the US. Quantifying patient ...

An electronic retinal implant has improved vision in people with age-related macular degeneration—but it isn’t a full ...

A retinal implant developed by Science Corp. has for the first time restored some functional vision to patients with a severe ...

A small wireless chip and a pair of smart glasses are offering new hope to people who thought they’d never read again. The ...

The intricate connection between ocular disorders and brain function is a rapidly emerging field that is reshaping our ...

A tiny wireless chip implanted in the back of the eye and a pair of high-tech glasses have partially restored vision to ...

People with a leading cause of blindness were able to read again thanks to a tiny wireless chip implanted in the back of the ...

Today, in the New England Journal of Medicin e, researchers announced that they restored some vision to elderly patients with ...